Clinical Trial Update: Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo [Phase 3]

View source ↗

Summary

A Phase 3 study assessing maintenance of sustained remission with CZP versus placebo in axial spondyloarthritis and ankylosing spondylitis has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Axial Spondyloarthritis

Drugs mentioned

• CZP (certolizumab pegol)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Axial Spondyloarthrithis, Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2020-04-21